Dublin, Sept. 14, 2017 -- The "Plasmapheresis Market - Global Opportunity Analysis and Industry Forecasts to 2022" report has been added to Research and Markets' offering.
Global plasmapheresis market is expected to reach USD 1,285.3 million by 2022 supported by a CAGR of 8.3% during the forecast period of 2017 to 2022.
The growth in this market is majorly driven by increasing incidence & prevalence of various autoimmune disorders, rising demand for source plasma from biopharmaceutical companies, and favorable reimbursement policies for plasmapheresis procedures. However, high cost of plasmapheresis procedure and lack of awareness about plasmapheresis will hamper the growth of this market to some extent during the forecast period.
Key questions answered in the report:
- Which are the high growth market segments in terms of product type, technology, application, end user and regions/countries?
- What is the historical market for plasmapheresis across the globe?
- What are the market forecasts and estimates from the period 2015-2022?
- What are the major drivers, restraints, opportunities and trends in the global plasmapheresis market?
- Who are the major players in various countries and what share of the market do they hold?
- What are the recent developments in the global plasmapheresis market?
- What are the different strategies adopted by the major players in the global plasmapheresis market?
- What are the geographical trends and high growth regions/ countries?
- Who are the local emerging players in the global plasmapheresis market and how do they compete with the global players?
Key Topics Covered:
1. Introduction
1.1. Market Ecosystem
1.2. Currency and Limitations
1.2.1. Currency
1.2.2. Limitations
1.3. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing Incidence of Autoimmune Diseases
4.2.1.2. Increasing Demand for Source Plasma from Biopharmaceutical Companies
4.2.1.3. Favorable Reimbursement Policies for Plasmapheresis Procedures
4.2.2. Restraints
4.2.2.1. High Cost of Plasmapheresis Devices & Procedures
4.2.2.2. Lack of Awareness About Plasmapheresis Procedures
4.2.2.3. Risk Associated with Plasmapheresis Procedures
4.2.3. Opportunity
4.2.3.1. Rising Demand for Plasmapheresis from Emerging Countries
4.3. Market Share Analysis, by Key Players
5. Plasmapheresis Market, By Product Type
5.1. Introduction
5.2. Instruments
5.3. Disposables
6. Plasmapheresis Market, By Technology
6.1. Introduction
6.2. Membrane Filtration
6.3. Centrifugation
7. Plasmapheresis Market, By Application
7.1. Introduction
7.2. Therapeutic Plasmapheresis
7.3. Source Plasma Collection
8. Plasmapheresis Market, By End User
8.1. Introduction
8.2. Biopharmaceutical Companies
8.3. Hospitals & Clinics
8.4. Others
9. Geographic Analysis
9.1. Introduction
9.2. North America
9.3. Europe
9.4. Asia-Pacific
9.5. Rest of The World
10. Company Profiles
10.1. Asahi Kasei Corporation
10.2. Terumo Corporation
10.3. Baxter International Inc.
10.4. B. Braun Melsungen Ag
10.5. Kawasumi Laboratories Inc.
10.6. Kaneka Corporation
10.7. Haemonetics Corporation
10.8. Fresenius Se & Co. Kgaa
10.9. Shanghai Dahua Medical Apparatus Co., Ltd.
10.10. Infomed Sa
11. Appendix
For more information about this report visit https://www.researchandmarkets.com/research/cw2gz5/plasmapheresis
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Blood Banking


Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Instagram Outage Disrupts Thousands of U.S. Users 



